Pivekimab Sunirine Drug Product (dp) 43624-0039
Product NDC
43624-0039- Manufacturer
- Bsp Pharmaceuticals S.p.a.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- May 29, 2026
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pivekimab Sunirine | 2 mg/mL |
Packaging Options(1)
5 TRAY in 1 BOX (43624-039-01) / 120 VIAL in 1 TRAY / 1 mL in 1 VIAL